Results 221 to 230 of about 3,851,527 (350)

Overall quality of life impact on candidates for septorhinoplasty according to the World Health Organization quality of life brief questionnaire (WHOQOL-Brief)

, 2022
Paula de Oliveira Oppermann, Luísi Rabaioli, Cássia Feijó, Natália Paseto Pilati, Emily Nicole Hrisomalos, Raphaella de Oliveira Migliavacca, Michelle Lavinsky‐Wolff   +6 more
openalex   +1 more source

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

Obesity in children and adolescents: Scoping exercise and prioritization for World Health Organization clinical guidelines. [PDF]

Ann N Y Acad Sci
Pardo-Hernandez H, Stifano A, Peña-Rosas JP, Branca F, Garcia-Casal MN.   +4 more
europepmc   +1 more source

Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis

, 2019
Eric D. McCollum, Siobhan P. Brown, Evangelyn Nkwopara, Tisungane Mvalo, Susanne May, Amy Sarah Ginsburg   +5 more
openalex   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines. [PDF]

J Natl Cancer Inst
Wilson BE, Wright K, Sengar M, Sullivan R, Pearson SA, Barton MB, Gyawali B, De Vries E, Moja L, Pramesh CS, Booth CM.   +10 more
europepmc   +1 more source

Cystic and Encapsulated Atypical Thymoma (World Health Organization Type B3) [PDF]

, 2019
Kaleigh E. Lindholm, César A. Moran
openalex   +1 more source

Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen, Wenting Huang, Yitian Liu, Xuan Chen, Buyu Ke, Qian Shen, Hanyu Cai, Jing Sun, Yan Li, Yungang Cao, Beilei Hu, Keyang Chen   +11 more
wiley   +1 more source

Should Digital Interventions for HIV Self-Testing Be Regulated with World Health Organization Prequalification?

JMIR Mhealth Uhealth
Fischer AE, Lalla-Edward ST, Edward V, Abrahams M, Shankland L, de Wit J.   +5 more
europepmc   +1 more source

Concurrent and convergent construct validities of the 5-item World Health Organization Ageism Experiences Scale in older French Canadians. [PDF]

Gerontologist
Levasseur M, Naud D, Murray AL.
europepmc   +1 more source